Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Market Access & Health Policy|October 9, 2023
Ivabradine in patients with heart failure: a systematic literature reviewZeba M Khan, Jean Baptiste Briere, Elzbieta Olewinska, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 7, 2018
Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available: A Validation Study Comparing Medication/Prescriber Visit-Based Algorithms with Diagnosis CodesWendy Dobson-Belaire, Jason Goodfield, Richard Borrelli, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 31, 2002
The spectrum of quality-of-life impairments in recurrent geriatric depressionP Murali Doraiswamy, Zeba M Khan, Rafe M J Donahue, et al.
Journal of Medical Economics|October 13, 2011
A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromesRisha Gidwani, Zeba M Khan, Pierre Fenaux, et al.
Health Affairs (Project Hope)|April 8, 2015
Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gainsDarius Lakdawalla, Jason Shafrin, Claudio Lucarelli, et al.
The Journal of Family Practice|May 10, 2003
Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysisMichael T Halpern, Zeba M Khan, Richard H Stanford, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practiceRichard J Willke, William Crown, Michael Del Aguila, et al.
The Annals of Pharmacotherapy|September 24, 2002
Antidepressant-induced sexual dysfunctionRazmic S Gregorian, Katharine A Golden, Asena Bahce, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest GroupTrevor Richter, Sandra Nestler-Parr, Robert Babela, et al.
Health Affairs (Project Hope)|April 8, 2015
Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995-2007Warren Stevens, Tomas J Philipson, Zeba M Khan, et al.
Pageof 4